Antonio Cannatelli

1.5k total citations
17 papers, 1.2k citations indexed

About

Antonio Cannatelli is a scholar working on Molecular Medicine, Endocrinology and Infectious Diseases. According to data from OpenAlex, Antonio Cannatelli has authored 17 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Medicine, 4 papers in Endocrinology and 3 papers in Infectious Diseases. Recurrent topics in Antonio Cannatelli's work include Antibiotic Resistance in Bacteria (14 papers), Tuberculosis Research and Epidemiology (3 papers) and Pharmaceutical and Antibiotic Environmental Impacts (3 papers). Antonio Cannatelli is often cited by papers focused on Antibiotic Resistance in Bacteria (14 papers), Tuberculosis Research and Epidemiology (3 papers) and Pharmaceutical and Antibiotic Environmental Impacts (3 papers). Antonio Cannatelli collaborates with scholars based in Italy, Greece and United States. Antonio Cannatelli's co-authors include Gian María Rossolini, Tommaso Giani, Vincenzo Di Pilato, Fabio Arena, Marco Maria D’Andrea, Simone Ambretti, Paolo Gaibani, Kyriaki Tryfinopoulou, Alkiviadis Vatopoulos and Viola Conte and has published in prestigious journals such as PLoS ONE, Scientific Reports and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Antonio Cannatelli

17 papers receiving 1.2k citations

Peers

Antonio Cannatelli
H. Dhanji United Kingdom
Steven H. Marshall United States
Christi L. McElheny United States
Antonio Cannatelli
Citations per year, relative to Antonio Cannatelli Antonio Cannatelli (= 1×) peers Lizhang Liu

Countries citing papers authored by Antonio Cannatelli

Since Specialization
Citations

This map shows the geographic impact of Antonio Cannatelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Cannatelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Cannatelli more than expected).

Fields of papers citing papers by Antonio Cannatelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Cannatelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Cannatelli. The network helps show where Antonio Cannatelli may publish in the future.

Co-authorship network of co-authors of Antonio Cannatelli

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Cannatelli. A scholar is included among the top collaborators of Antonio Cannatelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Cannatelli. Antonio Cannatelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Mattiuz, Giorgio, Alberto Antonelli, Tommaso Giani, et al.. (2020). mcr-1 Gene Expression Modulates the Inflammatory Response of Human Macrophages to Escherichia coli. Infection and Immunity. 88(8). 9 indexed citations
2.
Giani, Tommaso, Alberto Antonelli, Samanta Sennati, et al.. (2020). Results of the Italian infection-Carbapenem Resistance Evaluation Surveillance Trial (iCREST-IT): activity of ceftazidime/avibactam against Enterobacterales isolated from urine. Journal of Antimicrobial Chemotherapy. 75(4). 979–983. 15 indexed citations
3.
Pollini, Simona, Vincenzo Di Pilato, Tiziana Di Maggio, et al.. (2018). In vitro activity of N-acetylcysteine against Stenotrophomonas maltophilia and Burkholderia cepacia complex grown in planktonic phase and biofilm. PLoS ONE. 13(10). e0203941–e0203941. 33 indexed citations
4.
Cannatelli, Antonio, et al.. (2018). Synergistic Activity of Colistin in Combination With Resveratrol Against Colistin-Resistant Gram-Negative Pathogens. Frontiers in Microbiology. 9. 1808–1808. 39 indexed citations
5.
Pilato, Vincenzo Di, Olympia Zarkotou, Samanta Sennati, et al.. (2018). Characterization of Extensively Drug-Resistant or Pandrug-Resistant Sequence Type 147 and 101 OXA-48-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Patients in an Intensive Care Unit. Antimicrobial Agents and Chemotherapy. 62(7). 42 indexed citations
6.
Cannatelli, Antonio, Tommaso Giani, Noemi Aiezza, et al.. (2017). An allelic variant of the PmrB sensor kinase responsible for colistin resistance in an Escherichia coli strain of clinical origin. Scientific Reports. 7(1). 5071–5071. 32 indexed citations
7.
Coppi, Marco, Antonio Cannatelli, Alberto Antonelli, et al.. (2017). A simple phenotypic method for screening of MCR-1-mediated colistin resistance. Clinical Microbiology and Infection. 24(2). 201.e1–201.e3. 31 indexed citations
8.
Crawford, Matthew A., Lisa M. Leung, Sara Lomonaco, et al.. (2017). CXC Chemokines Exhibit Bactericidal Activity against Multidrug-Resistant Gram-Negative Pathogens. mBio. 8(6). 31 indexed citations
9.
Arena, Fabio, Lucia Henrici De Angelis, Marco Maria D’Andrea, et al.. (2017). Infections caused by carbapenem-resistant Klebsiella pneumoniae with hypermucoviscous phenotype: A case report and literature review. Virulence. 8(8). 1900–1908. 25 indexed citations
10.
Giani, Tommaso, Antonio Cannatelli, Vincenzo Di Pilato, et al.. (2016). Inhibitory activity of avibactam against selected β-lactamases expressed in an isogenic Escherichia coli strain. Diagnostic Microbiology and Infectious Disease. 86(1). 83–85. 8 indexed citations
11.
Passàli, Desiderio, et al.. (2016). Values of SP-A protein in the nasal mucosa. HNO. 64(9). 671–675. 1 indexed citations
12.
Pilato, Vincenzo Di, Fabio Arena, Carlo Tascini, et al.. (2016). mcr-1.2 , a New mcr Variant Carried on a Transferable Plasmid from a Colistin-Resistant KPC Carbapenemase-Producing Klebsiella pneumoniae Strain of Sequence Type 512. Antimicrobial Agents and Chemotherapy. 60(9). 5612–5615. 130 indexed citations
13.
Arena, Fabio, Lucia Henrici De Angelis, Antonio Cannatelli, et al.. (2016). Colistin Resistance Caused by Inactivation of the MgrB Regulator Is Not Associated with Decreased Virulence of Sequence Type 258 KPC Carbapenemase-Producing Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy. 60(4). 2509–2512. 25 indexed citations
14.
Cannatelli, Antonio, Alfonso Santos-López, Tommaso Giani, Bruno González‐Zorn, & Gian María Rossolini. (2015). Polymyxin Resistance Caused by mgrB Inactivation Is Not Associated with Significant Biological Cost in Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy. 59(5). 2898–2900. 49 indexed citations
15.
Cannatelli, Antonio, Vincenzo Di Pilato, Tommaso Giani, et al.. (2014). In Vivo Evolution to Colistin Resistance by PmrB Sensor Kinase Mutation in KPC-Producing Klebsiella pneumoniae Is Associated with Low-Dosage Colistin Treatment. Antimicrobial Agents and Chemotherapy. 58(8). 4399–4403. 113 indexed citations
16.
Cannatelli, Antonio, Tommaso Giani, Marco Maria D’Andrea, et al.. (2014). MgrB Inactivation Is a Common Mechanism of Colistin Resistance in KPC-Producing Klebsiella pneumoniae of Clinical Origin. Antimicrobial Agents and Chemotherapy. 58(10). 5696–5703. 286 indexed citations
17.
Cannatelli, Antonio, Marco Maria D’Andrea, Tommaso Giani, et al.. (2013). In Vivo Emergence of Colistin Resistance in Klebsiella pneumoniae Producing KPC-Type Carbapenemases Mediated by Insertional Inactivation of the PhoQ/PhoP mgrB Regulator. Antimicrobial Agents and Chemotherapy. 57(11). 5521–5526. 293 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026